213 related articles for article (PubMed ID: 30165445)
1. Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment.
Ferrari R; Pavasini R; Camici PG; Crea F; Danchin N; Pinto F; Manolis A; Marzilli M; Rosano GMC; Lopez-Sendon J; Fox K
Eur Heart J; 2019 Jan; 40(2):190-194. PubMed ID: 30165445
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Angina: Where Are We?
Balla C; Pavasini R; Ferrari R
Cardiology; 2018; 140(1):52-67. PubMed ID: 29874661
[TBL] [Abstract][Full Text] [Related]
3. Anti-anginal drugs: Systematic review and clinical implications.
Pavasini R; Camici PG; Crea F; Danchin N; Fox K; Manolis AJ; Marzilli M; Rosano GMC; Lopez-Sendon JL; Pinto F; Balla C; Ferrari R
Int J Cardiol; 2019 May; 283():55-63. PubMed ID: 30538056
[TBL] [Abstract][Full Text] [Related]
4. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Heidenreich PA; McDonald KM; Hastie T; Fadel B; Hagan V; Lee BK; Hlatky MA
JAMA; 1999 May; 281(20):1927-36. PubMed ID: 10349897
[TBL] [Abstract][Full Text] [Related]
6. Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart disease.
Chaitman BR; Sano J
Clin Cardiol; 2007 Feb; 30(2 Suppl 1):I25-30. PubMed ID: 18373327
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Ivabradine in Combination with Beta-Blockers in Patients with Stable Angina Pectoris: A Systematic Review and Meta-analysis.
Nedoshivin A; Petrova PTS; Karpov Y
Adv Ther; 2022 Sep; 39(9):4189-4204. PubMed ID: 35842897
[TBL] [Abstract][Full Text] [Related]
8. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
9. [Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of β-blockers, nitrates and calcium antagonists].
Hanai Y; Mita M; Hishinuma S; Shoji M
Yakugaku Zasshi; 2010 Nov; 130(11):1549-63. PubMed ID: 21048416
[TBL] [Abstract][Full Text] [Related]
10. WITHDRAWN: Trimetazidine for stable angina.
Ciapponi A; Pizarro R; Harrison J
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD003614. PubMed ID: 28319269
[TBL] [Abstract][Full Text] [Related]
11. Ivabradine: new drug. Best avoided in stable angina.
Prescrire Int; 2007 Apr; 16(88):53-6. PubMed ID: 17458043
[TBL] [Abstract][Full Text] [Related]
12. Trimetazidine for stable angina.
Ciapponi A; Pizarro R; Harrison J
Cochrane Database Syst Rev; 2005 Oct; (4):CD003614. PubMed ID: 16235330
[TBL] [Abstract][Full Text] [Related]
13. Anti-ischemic and pleiotropic effects of ranolazine in chronic coronary syndromes.
Manolis A; Kallistratos M; Poulimenos L; Thomopoulos C
Am J Med Sci; 2024 Mar; 367(3):155-159. PubMed ID: 38072070
[TBL] [Abstract][Full Text] [Related]
14. Ranolazine (Ranexa) for chronic stable angina.
Ndegwa S
Issues Emerg Health Technol; 2007 Jun; (99):1-6. PubMed ID: 17595750
[TBL] [Abstract][Full Text] [Related]
15. Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: A systematic review and meta-analysis.
Belsey J; Savelieva I; Mugelli A; Camm AJ
Eur J Prev Cardiol; 2015 Jul; 22(7):837-48. PubMed ID: 24776376
[TBL] [Abstract][Full Text] [Related]
16. Trimetazidine for stable angina pectoris.
Cross HR
Expert Opin Pharmacother; 2001 May; 2(5):857-75. PubMed ID: 11336628
[TBL] [Abstract][Full Text] [Related]
17. Stable angina pectoris: current medical treatment.
Siama K; Tousoulis D; Papageorgiou N; Siasos G; Tsiamis E; Bakogiannis C; Briasoulis A; Androulakis E; Tentolouris K; Stefanadis C
Curr Pharm Des; 2013; 19(9):1569-80. PubMed ID: 23016717
[TBL] [Abstract][Full Text] [Related]
18. Heart rate slowing versus other pharmacological antianginal strategies.
Diaz A; Tardif JC
Adv Cardiol; 2006; 43():65-78. PubMed ID: 16936473
[TBL] [Abstract][Full Text] [Related]
19. Conventional and novel drug therapeutics to relief myocardial ischemia.
Dvir D; Battler A
Cardiovasc Drugs Ther; 2010 Aug; 24(4):319-23. PubMed ID: 20658184
[TBL] [Abstract][Full Text] [Related]
20. Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris.
Pehrsson SK; Ringqvist I; Ekdahl S; Karlson BW; Ulvenstam G; Persson S
Clin Cardiol; 2000 Oct; 23(10):763-70. PubMed ID: 11061055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]